Intensity Therapeutics (INTS) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.31
-0.25
-0.19
-0.13

Details

Expected EPS
-0.17
Actual EPS
-0.13
Surprise EPS
0.04
Surprise Percent
+23.53%

Description

Intensity Therapeutics (INTS) has reported earnings of -0.13 per share for Q3 2025.

0 Comments

Share your thoughts